Dhand R, Hara K, Hiles I, Bax B, Gout I, Panayotou G, Fry M J, Yonezawa K, Kasuga M, Waterfield M D
Ludwig Institute for Cancer Research, London, UK.
EMBO J. 1994 Feb 1;13(3):511-21. doi: 10.1002/j.1460-2075.1994.tb06289.x.
Phosphatidylinositol (PI) 3-kinase has an 85 kDa subunit (p85 alpha) which mediates its association with activated protein tyrosine kinase receptors through SH2 domains, and an 110 kDa subunit (p110) which has intrinsic catalytic activity. Here p85 alpha and a related protein p85 beta are shown to form stable complexes with recombinant p110 in vivo and in vitro. Using a panel of glutathione S-transferase (GST) fusion proteins of the inter-SH2 region of p85, 104 amino acids were found to bind directly the p110 protein, while deletion mutants within this region further defined the binding site to a sequence of 35 amino acids. Transient expression of the mutant p85 alpha protein in mouse L cells showed it was unable to bind PI 3-kinase activity in vivo. Mapping of the complementary site of interaction on the p110 protein defined 88 amino acids in the N-terminal region of p110 which mediate the binding of this subunit to either the p85 alpha or the p85 beta proteins. The inter-SH2 region of p85 is predicted to be an independently folded module of a coiled-coil of two long anti-parallel alpha-helices. The predicted structure of p85 suggests a basis for the intersubunit interaction and the relevance of this interaction with respect to the regulation of the PI 3-kinase complex is discussed.
磷脂酰肌醇(PI)3激酶有一个85 kDa的亚基(p85α),它通过SH2结构域介导其与活化的蛋白酪氨酸激酶受体的结合,还有一个110 kDa的亚基(p110),它具有内在的催化活性。本文显示p85α和一种相关蛋白p85β在体内和体外均能与重组p110形成稳定的复合物。利用一组p85的SH2区域间的谷胱甘肽S-转移酶(GST)融合蛋白,发现104个氨基酸可直接与p110蛋白结合,而该区域内的缺失突变体进一步将结合位点确定为一个35个氨基酸的序列。突变型p85α蛋白在小鼠L细胞中的瞬时表达表明它在体内无法结合PI 3激酶活性。对p110蛋白上互补相互作用位点的定位确定了p110 N端区域的88个氨基酸,这些氨基酸介导该亚基与p85α或p85β蛋白的结合。p85的SH2区域间预计是由两个长的反平行α螺旋组成的卷曲螺旋的一个独立折叠模块。p85的预测结构为亚基间相互作用提供了基础,并讨论了这种相互作用与PI 3激酶复合物调节的相关性。